113 related articles for article (PubMed ID: 21764450)
1. Possibility of myelodysplastic syndromes screening using a complete blood automated cell count.
Rocco V; Maconi M; Gioia M; Silvestri MG; Tanca D; Catalano T; Avino D; Di Palma A; Rovetti A; Danise P
Leuk Res; 2011 Dec; 35(12):1623-7. PubMed ID: 21764450
[TBL] [Abstract][Full Text] [Related]
2. Automated screening for myelodysplastic syndromes through analysis of complete blood count and cell population data parameters.
Raess PW; van de Geijn GJ; Njo TL; Klop B; Sukhachev D; Wertheim G; McAleer T; Master SR; Bagg A
Am J Hematol; 2014 Apr; 89(4):369-74. PubMed ID: 24276948
[TBL] [Abstract][Full Text] [Related]
3. The technicon H6000 automated hematology analyzer in the diagnosis and classification of the myelodysplastic syndromes.
Orazi A; Milanesi B
Haematologica; 1990; 75(1):87-90. PubMed ID: 2338293
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of myelodysplasia syndrome screening during routine hematological analysis on the ADVIA 2120i.
Koenders MM; Taal PH; Kluiters-De Hingh Y; Van Wijk EM
Int J Lab Hematol; 2015 Apr; 37(2):e38-9. PubMed ID: 25046978
[No Abstract] [Full Text] [Related]
5. Automated neutrophil morphology and its utility in the assessment of neutrophil dysplasia.
Miguel A; Orero M; Simon R; Collado R; Perez PL; Pacios A; Iglesias R; Martinez A; Carbonell F
Lab Hematol; 2007; 13(3):98-102. PubMed ID: 17984041
[TBL] [Abstract][Full Text] [Related]
6. [The clinicopathological evaluation of automated cytochemical hematology system (Technicon H1) in patients with leukemia and myelodysplastic syndrome].
Koui F; Chiba T
Rinsho Byori; 1992 Jun; 40(6):586-94. PubMed ID: 1513030
[TBL] [Abstract][Full Text] [Related]
7. Reduction in multi-lineage and erythroid progenitors distinguishes myelodysplastic syndromes from non-malignant cytopenias.
Vercauteren SM; Bashashati A; Wu D; Brinkman RR; Eaves C; Eaves A; Karsan A
Leuk Res; 2009 Dec; 33(12):1636-42. PubMed ID: 19414193
[TBL] [Abstract][Full Text] [Related]
8. Peripheral blood MDS score: a new flow cytometric tool for the diagnosis of myelodysplastic syndromes.
Cherian S; Moore J; Bantly A; Vergilio JA; Klein P; Luger S; Bagg A
Cytometry B Clin Cytom; 2005 Mar; 64(1):9-17. PubMed ID: 15668954
[TBL] [Abstract][Full Text] [Related]
9. Classification and scoring systems in myelodysplastic syndromes: a retrospective analysis of 311 patients.
Navarro I; Ruiz MA; Cabello A; Collado R; Ferrer R; Hueso J; Martinez J; Miguel A; Orero MT; Pérez P; Nolasco A; Carbonell F
Leuk Res; 2006 Aug; 30(8):971-7. PubMed ID: 16423393
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic characteristics of patients with signs and symptoms of myelodysplastic syndromes in the State of Pará, Brazil.
Pinto GR; Overal DJ; Moraes LS; Van Den Berg AV; Lemos JA; Smith Mde A; Burbano RR
Genet Mol Res; 2005 Mar; 4(1):18-30. PubMed ID: 15841432
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of immature platelet fraction for the clinical evaluation of myelodysplastic syndromes.
Saigo K; Takenokuchi M; Imai J; Numata K; Isono S; Zenibayashi M; Tanioka H; Yoshioka T; Nishizawa A; Takada M; Nomura T; Kubota Y
Lab Hematol; 2009; 15(2):13-6. PubMed ID: 19561008
[TBL] [Abstract][Full Text] [Related]
12. [Preliminary study of diagnosis of patients with myelodysplastic syndromes by routine laboratory parameters].
Li L; Nie L; Yu MH; Zheng YZ; Zhang Y; Xu ZF; Hao YS; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2008 Sep; 29(9):623-8. PubMed ID: 19175993
[TBL] [Abstract][Full Text] [Related]
13. The value of cell cultures for the diagnosis of mixed myelodysplastic/myeloproliferative disorders.
Del Cañizo MC; Brufau A; Mota A; Lopez N; Fernandez ME; Vallejo C; Hernandez JM; Garcia JL; San Miguel JF
Haematologica; 1998 Jan; 83(1):3-7. PubMed ID: 9580461
[TBL] [Abstract][Full Text] [Related]
14. The presence of clonal cell subpopulations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia.
Cermák J; Belicková M; Krejcová H; Michalová K; Zilovcová S; Zemanová Z; Brezinová J; Sieglová Z
Leuk Res; 2005 Apr; 29(4):371-9. PubMed ID: 15725470
[TBL] [Abstract][Full Text] [Related]
15. Latency of onset of de novo myelodysplastic syndromes.
Wu PS; Hay AE; Thomas GE; Bowen DT
Haematologica; 2004 Nov; 89(11):1392-4. PubMed ID: 15531463
[TBL] [Abstract][Full Text] [Related]
16. [Myelodisplasic syndromes diagnosed in a geriatric hospital: morphological profile in 100 patients].
Dewulf G; Gouin I; Pautas E; Gaussem P; Chaïbi P; Andreux JP; Siguret V
Ann Biol Clin (Paris); 2004; 62(2):197-202. PubMed ID: 15047472
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric scoring system as a diagnostic and prognostic tool in myelodysplastic syndromes.
Chu SC; Wang TF; Li CC; Kao RH; Li DK; Su YC; Wells DA; Loken MR
Leuk Res; 2011 Jul; 35(7):868-73. PubMed ID: 21397943
[TBL] [Abstract][Full Text] [Related]
18. Therapy may unmask hypoplastic myelodysplastic syndrome that mimics aplastic anemia.
Konoplev S; Medeiros LJ; Lennon PA; Prajapati S; Kanungo A; Lin P
Cancer; 2007 Oct; 110(7):1520-6. PubMed ID: 17701956
[TBL] [Abstract][Full Text] [Related]
19. [Prospective clinical study of diagnosis and classification for 282 cases with primary myelodysplastic syndrome].
Wang XQ;
Zhonghua Xue Ye Xue Za Zhi; 2006 Aug; 27(8):546-9. PubMed ID: 17172130
[TBL] [Abstract][Full Text] [Related]
20. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications.
Lorand-Metze I; Pinheiro MP; Ribeiro E; de Paula EV; Metze K
Leuk Res; 2004 Jun; 28(6):587-94. PubMed ID: 15120935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
